ZINZINO AB (PUBL): PRELIMINARY SALES REPORT JANUARY 2024
Zinzino group revenue increased with a total of 15%, compared with the previous year.
The revenue in January for Zinzino's sales markets increased by 17% and amounted to SEK 140.2 (120.3) million. Faun Pharma's external sales decreased by 11% and amounted to SEK 8.1 (9.1) million. Overall, the Group increased revenues by 15% to SEK 148.3 (129.4) million compared with the previous year.
Revenues were distributed as follows:
| Regions, mSEK | 24-Jan | 23-Jan | Change |
| The Nordics | 22.6 | 23.4 | -3% |
| Central Europe | 41,0 | 28.5 | 44% |
| East Europe | 31.8 | 32.8 | -3% |
| South & West Europe | 21.8 | 15.9 | 37% |
| The Baltics | 8,0 | 7.4 | 8% |
| North America | 10.1 | 6.3 | 60% |
| Asia-Pacific | 3.9 | 4.6 | -15% |
| Africa | 1,0 | 1.4 | -29% |
| Zinzino | 140.2 | 120.3 | 17% |
| Faun Pharma | 8.1 | 9.1 | -11% |
| Zinzino Group | 148.3 | 129.4 | 15% |
Countries in regions:
-The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden
-Central Europe: Austria, Germany, Switzerland
-East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania
-South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Turkey
-The Baltics: Estonia, Latvia, Lithuania
-North America: Canada, USA, Mexico
-Asia-Pacific: Australia, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand
-Africa: South Africa
For more information:
Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, zinzino.com
Pictures for publication free of charge: [email protected]
Certified Adviser: Carnegie Investment Bank AB (publ)